Details for 2017743136

Up to date per 01.04.2026

Actions

Title / Product Name

C17-, C20- UND C21-SUBSTITUIERTE NEUROAKTIVE STEROIDE UND DEREN VERFAHREN ZUR VERWENDUNG

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017743136

EP Publication Number

3481845

E-Number

1611230

Language

PCT Number

US17041600

Publication Date

15.05.2019 A

13.09.2023 B1

Registration Date

13.09.2023

AT Publication Date

15.10.2023

Application Date

11.07.2017

Registration Number

Priorities

11.07.2016

201662360813 P

11.07.2016

201662360847 P

18.11.2016

201662424083 P

IPC

C07J 7/00 20060101AFI20220729BHEP

Maximum Duration of Protection

11.07.2037

Owner

Sage Therapeutics, Inc.215 First Street Cambridge, MA 02142US

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT

Inventor

ROBICHAUD, Albert, J.2 Earhart Street 915 Cambridge, MA 02141US

MARTINEZ BOTELLA, Gabriel17 Parmenter Road Wayland, MA 01778US

HARRISON, Boyd, L.9 Wheatston Court Princeton Junction, NJ 08550US

SALITURO, Francesco, G.25 Baker Drive Marlborough, MA 01752US

GRIFFIN, Andrew232 Rue Barette L'ile Bizard, Quebec H9CZYCA

BLANCO-PILLADO, Maria, Jesus72 Thesda Street Arlington, MA 02474US

Information about Fees